{"created":"2023-05-15T14:50:33.049230+00:00","id":69130,"links":{},"metadata":{"_buckets":{"deposit":"19e6afc9-8235-4d4d-ba37-c25a56c671ce"},"_deposit":{"created_by":1,"id":"69130","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"69130"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00069130","sets":["10:28"]},"author_link":["678376","678375","678372","678368","678377","678370","678371","678373","678374","678369"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2007-10-13","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"PURPOSE:C-11 methionine is a tracer for PET that can be used to assess metabolism of amino acid in tumor cells. The purpose of this study is to assess the ability of C-11 methionine PET (MET-PET) to predict prognosis of patient with adenocarcinoma in head and neck treated by carbon ion radiotherapy (CIRT).\nMETHOD AND MATERIALS:We studied consecutive 23 patients with proven adenocarcinoma in head and neck who had been referred to our hospital for CIRT. 15 patients were male and 8 patients were female. The average patient age was 61.9 years (range 40 to 82). Patients were followed for 5.1 to 89.8 months (mean: 31.9 months) after CIRT. We evaluated the lesion semi-quantitatively on the basis of the Tumor-to-Normal-tissue Ratio (TNR). We statistically analyzed the relationship between tumor MET uptake level at pre and post CIRT, recurrence or metastasis rate, and patient prognosis using Kaplan-Meier analysis method.\nRESULTS:There were significant relationships between the level of tumor activity before CIRT and patients prognosis, recurrence and metastasis rate (p=0.029, 0.043, and 0.014) from Kaplan-Meier analysis. The level of tumor activity after CIRT also significantly related to patients prognosis, recurrence and metastasis rate (p=0.049, 0.043, and 0.014). No statistically significant relationship was observed between tumor uptake change after CIRT and survival rate.\nCONCLUSIONS:MET-PET is useful to predict patients survival rate, recurrence and metastasis rate in patients with head and neck adenocarcinoma treated by CIRT.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"89th AAOMS Annual Meeting, Scientific Sessions and Exhibition in conjunction with the Japanese Society of Oral and Maxillofacial Surgeons and the Korean Association of Oral and Maxillofacial Surgeons","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Hasebe, Mitsuhiko"}],"nameIdentifiers":[{"nameIdentifier":"678368","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Yoshikawa, Kyosan"}],"nameIdentifiers":[{"nameIdentifier":"678369","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ishikawa, Hiroyuki"}],"nameIdentifiers":[{"nameIdentifier":"678370","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sagou, Kenji"}],"nameIdentifiers":[{"nameIdentifier":"678371","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kawaguchi, Koji"}],"nameIdentifiers":[{"nameIdentifier":"678372","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Seto, Kanichi"}],"nameIdentifiers":[{"nameIdentifier":"678373","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"長谷部 充彦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"678374","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉川 京燦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"678375","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石川 博之","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"678376","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"佐合 賢治","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"678377","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"Usefulness of Methionine PET for predicting prognosis of patient with adenoc arcinoma in head and neck treated by carbon ion radiotherapy","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Usefulness of Methionine PET for predicting prognosis of patient with adenoc arcinoma in head and neck treated by carbon ion radiotherapy"}]},"item_type_id":"10005","owner":"1","path":["28"],"pubdate":{"attribute_name":"公開日","attribute_value":"2007-10-15"},"publish_date":"2007-10-15","publish_status":"0","recid":"69130","relation_version_is_last":true,"title":["Usefulness of Methionine PET for predicting prognosis of patient with adenoc arcinoma in head and neck treated by carbon ion radiotherapy"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T20:18:08.008750+00:00"}